Ranbaxy Laboratories
Headquarters in India
Ranbaxy Laboratories website: http://www.ranbaxy.com
🔎 Run a search for “Ranbaxy Laboratories”
Get RSS feed of these resultsAll stories
President Clinton Announces Breakthroughs in HIV/AIDS Treatment for Children— 3-in-1 Pill for less than $60 Annually and 45% Price Reductions for other Pediatric Drugs
Author: Clinton Foundation [USA]
President Bill Clinton announced today that his foundation has negotiated new agreements to lower the price of HIV/AIDS treatment for children. Cipla and Ranbaxy will price a new child-friendly product...for less than $60 per year... The new prices...
- Related stories: Cipla, Ranbaxy to cut paediatric antiretroviral drug prices to as low as $60/year for poor countries ahead of World AIDS Day under deal with Clinton Foundation
- Related companies: Abbott Laboratories Aurobindo Pharmaceuticals Bristol-Myers Squibb Cipla Merck Ranbaxy Laboratories Roche
Indian Firms to Make HIV Drug - Gilead Sciences licenses AIDS treatment Tenofovir to eight more Indian companies
Author: Red Herring [USA]
Eight more Indian companies have received nonexclusive licenses from Gilead Sciences to manufacture and distribute the HIV drug Tenofovir...The [eight] Indian drug companies that struck the licensing deal were [Ranbaxy Laboratories], Aurobindo Pharma,...
After Glaxo patent, it is Novartis' turn [India]
Author: Amrita Nair-Ghaswalla, Times of India
The success of activists in forcing GlaxoSmithKline to withdraw the patent application for its HIV/AIDS drug combivir in India is now spurring on others. Cancer patients and non-government organisations have decided to rally against Swiss...
- Related companies: Cipla GlaxoSmithKline Hetero Novartis Ranbaxy Laboratories
Patent or patient? How Washington uses trade deals to protect drugs
Author: Alan Beattie, Andrew Jack, Amy Kazmin, Financial Times
The "lives of hundreds of thousands of Thai citizens" would be put at risk if negotiators accepted Washington's demands for greater protection of drug companies' intellectual property rights, he [William Aldis, World Health Organization director in...
- Related stories: Patent or patient? How Washington uses trade deals to protect drugs
- Related companies: Abbott Laboratories Cipla Ranbaxy Laboratories
Annan pushes AIDS drug makers to lower prices
Author: Irwin Arieff, Reuters
U.N. Secretary-General Kofi Annan encouraged executives from nine drug companies on Monday to lower prices of AIDS medicines and step up efforts to develop AIDS drugs and diagnostics for children... At his request, the officials agreed to review the...
- Related stories: Kofi Annan pushes AIDS drug makers on prices, drugs & diagnostics for children - 9 major firms agree to review prices of medicines & diagnostics, develop paediatric formulations
- Related companies: Aspen Pharmacare Aurobindo Pharmaceuticals BD (Becton, Dickinson) Bristol-Myers Squibb GlaxoSmithKline Hetero Johnson & Johnson Merck Ranbaxy Laboratories
"AIDS pandemic is still outpacing our efforts", broad partnership needed to step up response,says Secretary-General after meeting with pharmaceutical executives
Author: United Nations
Following is UN Secretary-General Kofi Annan’s statement, issued following a meeting with top pharmaceutical executives on HIV/AIDS, in New York, 24 July:....In the five years since I first met with pharmaceutical company executives, we have seen...
- Related stories: Kofi Annan pushes AIDS drug makers on prices, drugs & diagnostics for children - 9 major firms agree to review prices of medicines & diagnostics, develop paediatric formulations
- Related companies: Aspen Pharmacare Aurobindo Pharmaceuticals BD (Becton, Dickinson) Bristol-Myers Squibb GlaxoSmithKline Hetero Johnson & Johnson Merck Ranbaxy Laboratories
Public health, innovation and intellectual property rights
Author: Commission on Intellectual Property Rights, Innovation & Public Health, World Health Organization (WHO)
Developing countries are...largely dependent on the products of innovation designed principally to meet the health-care needs of developed countries. In some cases these products meet their needs...but in others, no treatments are available for...
- Related stories: WHO meeting examines failure of global drug patents & pricing to meet health needs of the world's poor
- Related companies: Abbott Laboratories AstraZeneca Bayer Boehringer Ingelheim Bristol-Myers Squibb Gilead Sciences GlaxoSmithKline Johnson & Johnson Merck Novartis Pfizer Ranbaxy Laboratories Roche Sanofi Pasteur (part of Sanofi-Aventis) Sanofi-Aventis
WHO meeting examines failure of global drug patents & pricing to meet health needs of the world's poor
Author: Comisión de Derechos de Propiedad Intelectual, Innovación y Salud Pública, Organización Mundial de la Salud (OMS)
...los países en desarrollo dependen en gran medida de los productos innovadores diseñados principalmente para suplir las necesidades asistenciales de los países desarrollados. En algunos casos, esos productos cubren sus necesidades...pero en otros, o...
- Related stories: WHO meeting examines failure of global drug patents & pricing to meet health needs of the world's poor
- Related companies: Abbott Laboratories AstraZeneca Bayer Boehringer Ingelheim Bristol-Myers Squibb Gilead Sciences GlaxoSmithKline Johnson & Johnson Merck Novartis Pfizer Ranbaxy Laboratories Roche Sanofi Sanofi Pasteur (part of Sanofi)